Department of Neurology, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.
Department of Neurology, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Comb Chem High Throughput Screen. 2024;27(7):1022-1032. doi: 10.2174/1386207326666230816162113.
(APS), a group of bioactive compounds obtained from the natural source (AM), exhibits numerous pharmacological actions in the central nervous system, such as anti-inflammatory, antioxidant, and immunomodulatory properties. Despite the remarkable benefits, the effectiveness of APS in treating anti- N-methyl-D-aspartate receptor (NMDAR) encephalitis and the corresponding mechanism have yet to be fully understood. As such, this study aims to investigate the impact of APS on anti-NMDAR encephalitis and explore the potential molecular network mechanism.
The impact of APS intervention on mice with anti-NMDAR encephalitis was assessed, and the possible molecular network mechanism was investigated utilizing network pharmacology and bioinformatics techniques such as Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG),protein-protein interaction (PPI) network, and molecular docking. Enzymelinked immunosorbent assay (ELISA) was applied to detect the expression of core target proteins.
APS significantly ameliorated cognitive impairment and reduced susceptibility to PTZinduced seizures in mice with anti-NMDAR encephalitis, confirming the beneficial effect of APS on anti-NMDAR encephalitis. Seventeen intersecting genes were identified between APS and anti- NMDAR encephalitis. GO and KEGG analyses revealed the characteristics of the intersecting gene networks. STRING interaction in the PPI network was applied to find crucial molecules. The results of molecular docking suggested that APS may regulate interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) as potential targets in anti-NMDAR encephalitis. Furthermore, the levels of IL-1β, IL-6, and TNF-α detected by ELISA in anti-NMDAR encephalitis mice were significantly downregulated in response to the administration of APS.
The findings of this study demonstrate the significant role of APS in the treatment of anti-NMDAR encephalitis, as it effectively suppresses inflammatory cytokines. These results suggest that APS has the potential to be considered as a viable herbal medication for the treatment of anti-NMDAR encephalitis.
(APS),一种从天然来源(AM)获得的生物活性化合物群,在中枢神经系统中具有多种药理作用,如抗炎、抗氧化和免疫调节特性。尽管有显著的益处,但 APS 治疗抗 N-甲基-D-天冬氨酸受体(NMDAR)脑炎的效果及其相应的机制尚未得到充分理解。因此,本研究旨在探讨 APS 对抗 NMDAR 脑炎的影响,并探索潜在的分子网络机制。
评估 APS 干预对抗 NMDAR 脑炎小鼠的影响,利用网络药理学和生物信息学技术,如基因本体(GO)、京都基因与基因组百科全书(KEGG)、蛋白质-蛋白质相互作用(PPI)网络和分子对接,研究可能的分子网络机制。采用酶联免疫吸附试验(ELISA)检测核心靶蛋白的表达。
APS 显著改善了抗 NMDAR 脑炎小鼠的认知障碍,降低了对 PTZ 诱导的癫痫发作的易感性,证实了 APS 对抗 NMDAR 脑炎的有益作用。在 APS 和抗 NMDAR 脑炎之间确定了 17 个相交基因。GO 和 KEGG 分析揭示了相交基因网络的特征。在 PPI 网络中的 STRING 相互作用用于找到关键分子。分子对接的结果表明,APS 可能作为抗 NMDAR 脑炎的潜在靶点,调节白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)。此外,ELISA 检测到抗 NMDAR 脑炎小鼠中 IL-1β、IL-6 和 TNF-α的水平在用 APS 治疗后显著下调。
本研究结果表明,APS 在治疗抗 NMDAR 脑炎中具有重要作用,因为它能有效抑制炎症细胞因子。这些结果表明,APS 有潜力被认为是治疗抗 NMDAR 脑炎的一种可行的草药药物。